Global Oral Mucositis Market report from Global Insight Services is the single authoritative source of intelligence on Oral Mucositis Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Oral Mucositis also called as stomatitis is an acute inflammation of the mucous membranes of mouth/oral cavity following the systemic cancer therapy and/or radiation therapy.
Download Free Sample of Report- https://www.globalinsightservices.com/request-sample/GIS31248
The most common cause of Oral Mucositis is cancer treatments. The frequent treatments of chemotherapy, radiation of the head, chest, or neck, bone marrow and stem cell transplants can cause mucositis.
Symptoms include dry mouth, shiny, swollen, or red gums, mouth pain, painful mouth sores, infection, blood in the mouth, pain or a mild burning sensation while eating, difficulty in swallowing or talking.
Doctors can generally make a diagnosis based on the timing of symptoms relative to therapy and the clinical appearance of mouth. There is no laboratory or radiographic testing that is needed to make the diagnosis. Because viral or fungal (yeast) infections can occur in mouth, especially if white blood cell count is low, a culture, or a scraping may be done to rule out an infection.
The most common treatments for Oral Mucositis are medication and mouthwashes and oral care.
Request For Customization – https://www.globalinsightservices.com/request-customization/GIS31248
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Oral Mucositis treatment such as SGX942, Avasopasem, EC-18 and others. Key players involved in the development of therapies to treat Oral Mucositis are Soligenix, Galera Therapeutics, Enzychem Lifesciences Corp, and others. One drug is under Pre-Registration, one drug is under Phase III and four drugs are in Phase II clinical trials and some other drugs are under Phase I, IND/CTA filed, preclinical and discovery stages of development.
In December 2022, Galera Therapeutics submitted New Drug Application (NDA) to the U.S. Food and Drug Administration for Avasopasem for severe oral mucositis.
Report Highlights
Global Insight Service’s, Oral Mucositis – Drug Pipeline Landscape, 2023 report provides an overview of the Oral Mucositis pipeline drugs. This report covers detailed insights on Oral Mucositis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Oral Mucositis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
For In-Depth Competitive Analysis, Purchase this Report– https://www.globalinsightservices.com/inquiry-before-buying/GIS31248
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Reasons to Buy
Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/